Amylin continues slide on diabetes drug concerns – Forbes

« « Shionogi Completes Acquisition of Sciele – MarketWatch  |  MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes … – FOXBusiness » »

Amylin continues slide on diabetes drug concerns – Forbes

Friday, October 10th, 2008    Subscribe To Our Feed

Amylin continues slide on diabetes drug concerns
Forbes,?NY?- 13 hours ago
In all, the company and Food and Drug Administration have reported six deaths in patients who had taken the diabetes treatment. The reports sparked a stock

Source:Amylin continues slide on diabetes drug concerns – Forbes

No Tags

Share and Enjoy:
  • Digg
  • Furl
  • del.icio.us
  • Slashdot
  • Smarking
  • NewsVine
  • SphereIt
  • blinkbits
  • Reddit
  • Blue Dot
  • StumbleUpon
  • BlinkList
  • Spurl
  • Netscape

Leave a Reply

Comment moderation is enabled. Your comment may take some time to appear.